You are here:Home-Chemical Inhibitors & Agonists-Membrane Transporter/Ion Channel-CFTR-Elexacaftor
Elexacaftor

Chemical Structure : Elexacaftor

CAS No.: 2216712-66-0

Elexacaftor (VX-445, WHO11180)

Catalog No.: PC-73172Not For Human Use, Lab Use Only.

Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector and modulator for cystic fibrosis treatment.

Packing Price Stock Quantity
1 mg $98 In stock
5 mg $198 In stock
10 mg $298 In stock
25 mg $488 In stock
50 mg $758 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector and modulator for cystic fibrosis treatment.

Physicochemical Properties

M.Wt 597.658
Formula C26H34F3N7O4S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(S)-N-((1,3-Dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-(2,2,4-trimethylpyrrolidin-1-yl)nicotinamide

References

1. Keating D, et al. N Engl J Med. 2018 Oct 25;379(17):1612-1620.

2. Taylor-Cousar JL, et al. ERJ Open Res. 2019 Jun 17;5(2):00082-2019.

3. Middleton PG, et al. N Engl J Med. 2019 Nov 7;381(19):1809-1819.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: